Bicalutamide Tablet
Product Images NDC 16729-023

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 16729-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bicalutamide 50mg (30 tablet count bottle label)

Bicalutamide Tablets USP, 50 mg oral tablets, labeled for prescription use only. The label states each tablet contains 50 mg of Bicalutamide and includes storage instructions to keep at 20 to 25°C. The package contains 30 tablets and is manufactured by Accord Healthcare Inc. with manufacturing by Intas Pharmaceuticals Limited, India. The NDC is 16729-023-10.*

FDA Label Image

Fig_1 (Bicalutamide Fig 1)

A survival curve graph comparing the proportion surviving over time between 'Bicalutamide plus LHRH-A' and 'Flutamide plus LHRH-A'. The x-axis represents days to death, ranging from 0 to 1825 days, and the y-axis represents the proportion surviving, ranging from 0.0 to 1.0. The graph shows two curves tracking survival over time for the two treatment groups.*

FDA Label Image

Fig_2 (Bicalutamide Fig 2)

A Kaplan-Meier survival curve showing the proportion of patients not progressing over time in days. Two treatment groups are compared: Bicalutamide plus LHRH-A (solid line) and Flutamide plus LHRH-A (dashed line). The vertical axis represents the proportion not progressing, while the horizontal axis shows days to progression up to approximately 1825 days.*

FDA Label Image

Chem (Bicalutamide Str)

Chemical structure of Bicalutamide showing the molecular arrangement of its atoms including functional groups such as amide, sulfonyl, and trifluoromethyl, along with the molecular formula C18H14N2O4F4S.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.